Literature DB >> 10853876

Comparison of several approaches of therapeutic drug monitoring of cyclosporin A based on individual pharmacokinetics.

R Wacke1, B Rohde, G Engel, G Kundt, E M Hehl, R Bast, H Seiter, B Drewelow.   

Abstract

OBJECTIVE: The clinical outcome of patients after organ transplantation is correlated with cyclosporin A (CyA) exposure. It is generally accepted that the area under the concentration-time curve (AUC) provides a reliable means for drug exposure. However, in routine therapeutic drug monitoring (TDM) of CyA, trough levels are mostly used. Currently, a number of different new concepts of CyA-TDM, including approaches such as single, double or triple time-point and abbreviated AUC determinations, have been introduced. The purpose of this study was to compare the predictive value of the different strategies of TDM.
METHODS: Calculations were based on 40 individual concentration time profiles after oral administration of CyA to patients who had been included into an ongoing prospective clinical trial. Non-compartmental analysis was used to calculate the AUC0-12h. Multiple linear regression was performed to describe the relationship between the different sets of blood concentrations and the respective AUC0-12h as well as to evaluate their predictive value regarding AUC. Predictive performance was assessed by prediction bias and prediction precision, which were estimated as the mean prediction error and root mean squared error, respectively.
RESULTS: When comparing the various combinations of time points, it was found that one-point approaches showed the strongest differences with regard to the predictive value; the associated r2 values differed from 0.203 to 0.792. The two and three time-point approaches showed lower differences - r2 0.802-0.972. The four-point and five-point approaches (r2 0.942-0.982) were the strongest predictors for CyA AUC0-12h. Relative bias ranged from -27.7% to 63.8% and changed significantly when multiple-point predictors were used. In those cases, the predictive performance improved. Considering the predictive performance as well as the smallest bias and highest prediction precision, C3, C1 + C3, C1 + C3 + C6 and C1 + C2 + C3 + C6 were the best predictors.
CONCLUSION: The results of this study indicate that in kidney transplant patients a clinically sufficient precise estimation of the CyA AUC is possible using two or three concentration time points.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10853876     DOI: 10.1007/s002280050718

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  7 in total

1.  [Cyclosporine monitoring in patients with chronic uveitis].

Authors:  S Schmidt; U Pleyer
Journal:  Ophthalmologe       Date:  2005-04       Impact factor: 1.059

2.  Population pharmacokinetic model to predict steady-state exposure to once-daily cyclosporin microemulsion in renal transplant recipients.

Authors:  Franziska Schädeli; Hans-Peter Marti; Felix J Frey; Dominik E Uehlinger
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

3.  Population pharmacokinetics of ciclosporin in haematopoietic allogeneic stem cell transplantation with emphasis on limited sampling strategy.

Authors:  Abraham J Wilhelm; Peer de Graaf; Agnes I Veldkamp; Jeroen J W M Janssen; Peter C Huijgens; Eleonora L Swart
Journal:  Br J Clin Pharmacol       Date:  2012-04       Impact factor: 4.335

4.  Population pharmacokinetics of cyclosporine A in Japanese renal transplant patients: comprehensive analysis in a single center.

Authors:  Akira Okada; Hidetaka Ushigome; Misaki Kanamori; Aya Morikochi; Hidefumi Kasai; Tadashi Kosaka; Takatoshi Kokuhu; Asako Nishimura; Nobuhito Shibata; Keizo Fukushima; Norio Yoshimura; Nobuyuki Sugioka
Journal:  Eur J Clin Pharmacol       Date:  2017-06-15       Impact factor: 2.953

5.  Prediction of cyclosporine A blood levels: an application of the adaptive-network-based fuzzy inference system (ANFIS) in assisting drug therapy.

Authors:  Sezer Gören; Adem Karahoca; Filiz Y Onat; M Zafer Gören
Journal:  Eur J Clin Pharmacol       Date:  2008-05-06       Impact factor: 2.953

6.  Limited sampling strategies using Bayesian estimation or multilinear regression for cyclosporin AUC(0-12) monitoring in cardiac transplant recipients over the first year post-transplantation.

Authors:  C Monchaud; A Rousseau; F Leger; O J David; J Debord; T Dantoine; P Marquet
Journal:  Eur J Clin Pharmacol       Date:  2003-03-06       Impact factor: 2.953

7.  Dose adjustment strategy of cyclosporine A in renal transplant patients: evaluation of anthropometric parameters for dose adjustment and C0 vs. C2 monitoring in Japan, 2001-2010.

Authors:  Takatoshi Kokuhu; Keizo Fukushima; Hidetaka Ushigome; Norio Yoshimura; Nobuyuki Sugioka
Journal:  Int J Med Sci       Date:  2013-09-23       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.